Cancer treatment method

An object of the present invention is to provide a formulation that avoids an induction of inflammatory cytokine production caused by drugs when suppressing the progression, suppressing recurrence and/ or treating the cancer by the STING-acting compound. The present invention relates to a formulatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KOIKE, TOMOYA, TAKEDA, KAZUHIKO, KATSUBE, AKIRA, MIYATA, RYOHEI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KOIKE, TOMOYA
TAKEDA, KAZUHIKO
KATSUBE, AKIRA
MIYATA, RYOHEI
description An object of the present invention is to provide a formulation that avoids an induction of inflammatory cytokine production caused by drugs when suppressing the progression, suppressing recurrence and/ or treating the cancer by the STING-acting compound. The present invention relates to a formulation in which a STING-agonizing compound is administered in combination with a corticosteroid during cancer progression suppression, recurrence suppression and / or treatment, and a method of avoiding induction of inflammatory cytokine production by prescribing a reduced dose of a STING agonist compound in combination with an antineoplastic agent and further in combination with a corticosteroid.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202200136A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202200136A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202200136A3</originalsourceid><addsrcrecordid>eNrjZBB3TsxLTi1SKClKTSzJTc0rUchNLcnIT-FhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGRkYGBobGZo7GxKgBAMqMIfM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cancer treatment method</title><source>esp@cenet</source><creator>KOIKE, TOMOYA ; TAKEDA, KAZUHIKO ; KATSUBE, AKIRA ; MIYATA, RYOHEI</creator><creatorcontrib>KOIKE, TOMOYA ; TAKEDA, KAZUHIKO ; KATSUBE, AKIRA ; MIYATA, RYOHEI</creatorcontrib><description>An object of the present invention is to provide a formulation that avoids an induction of inflammatory cytokine production caused by drugs when suppressing the progression, suppressing recurrence and/ or treating the cancer by the STING-acting compound. The present invention relates to a formulation in which a STING-agonizing compound is administered in combination with a corticosteroid during cancer progression suppression, recurrence suppression and / or treatment, and a method of avoiding induction of inflammatory cytokine production by prescribing a reduced dose of a STING agonist compound in combination with an antineoplastic agent and further in combination with a corticosteroid.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220101&amp;DB=EPODOC&amp;CC=TW&amp;NR=202200136A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220101&amp;DB=EPODOC&amp;CC=TW&amp;NR=202200136A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOIKE, TOMOYA</creatorcontrib><creatorcontrib>TAKEDA, KAZUHIKO</creatorcontrib><creatorcontrib>KATSUBE, AKIRA</creatorcontrib><creatorcontrib>MIYATA, RYOHEI</creatorcontrib><title>Cancer treatment method</title><description>An object of the present invention is to provide a formulation that avoids an induction of inflammatory cytokine production caused by drugs when suppressing the progression, suppressing recurrence and/ or treating the cancer by the STING-acting compound. The present invention relates to a formulation in which a STING-agonizing compound is administered in combination with a corticosteroid during cancer progression suppression, recurrence suppression and / or treatment, and a method of avoiding induction of inflammatory cytokine production by prescribing a reduced dose of a STING agonist compound in combination with an antineoplastic agent and further in combination with a corticosteroid.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBB3TsxLTi1SKClKTSzJTc0rUchNLcnIT-FhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGRkYGBobGZo7GxKgBAMqMIfM</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>KOIKE, TOMOYA</creator><creator>TAKEDA, KAZUHIKO</creator><creator>KATSUBE, AKIRA</creator><creator>MIYATA, RYOHEI</creator><scope>EVB</scope></search><sort><creationdate>20220101</creationdate><title>Cancer treatment method</title><author>KOIKE, TOMOYA ; TAKEDA, KAZUHIKO ; KATSUBE, AKIRA ; MIYATA, RYOHEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202200136A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KOIKE, TOMOYA</creatorcontrib><creatorcontrib>TAKEDA, KAZUHIKO</creatorcontrib><creatorcontrib>KATSUBE, AKIRA</creatorcontrib><creatorcontrib>MIYATA, RYOHEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOIKE, TOMOYA</au><au>TAKEDA, KAZUHIKO</au><au>KATSUBE, AKIRA</au><au>MIYATA, RYOHEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cancer treatment method</title><date>2022-01-01</date><risdate>2022</risdate><abstract>An object of the present invention is to provide a formulation that avoids an induction of inflammatory cytokine production caused by drugs when suppressing the progression, suppressing recurrence and/ or treating the cancer by the STING-acting compound. The present invention relates to a formulation in which a STING-agonizing compound is administered in combination with a corticosteroid during cancer progression suppression, recurrence suppression and / or treatment, and a method of avoiding induction of inflammatory cytokine production by prescribing a reduced dose of a STING agonist compound in combination with an antineoplastic agent and further in combination with a corticosteroid.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW202200136A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Cancer treatment method
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A55%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOIKE,%20TOMOYA&rft.date=2022-01-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202200136A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true